News & Updates
Filter by Specialty:
Sacubitril/valsartan equals enalapril, valsartan alone for preventing AF in HF
Sacubitril/valsartan performs comparably as enalapril or valsartan alone in preventing atrial fibrillation (AF) occurrence in patients with heart failure (HF), reports a recent meta-analysis.
Sacubitril/valsartan equals enalapril, valsartan alone for preventing AF in HF
31 Jan 2022
Treatment-resistant hypertension can be monitored using home BP
Home blood pressure monitoring (HBPM) may be a valuable method of monitoring for treatment-resistant hypertension and for subsequent risk stratification, a recent study has found.
Treatment-resistant hypertension can be monitored using home BP
27 Jan 2022
Esaxerenone produces favourable night-time BP-lowering effect in Asians
The novel highly selective mineralocorticoid receptor blocker esaxerenone holds promise in the treatment of nocturnal hypertension, yielding substantial reductions in night-time blood pressure (BP), especially in Japanese patients with a riser pattern, as well as in N-terminal pro B-type natriuretic peptide (NT-proBNP) levels, according to a post hoc analysis of a phase III study.